Features
Search Archives
Life Science News
Press Release
All News
Other News Sites
DataStoreX
IAQTimes
ElectronixTimes
Month
January
February
March
April
May
June
July
August
September
October
November
December
Year
2003
2004
2005
2006
2007
*
Select a date to view other archived news.
Date
News
Jul. 30, 2008
Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
Jul. 30, 2008
Elan and Wyeth Present Encouraging Results from Phase 2 Clinical Trial of Bapineuzumab at International Conference on Alzheimer's Disease
Jul. 30, 2008
Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
Jul. 23, 2008
Alcon's Second Quarter Sales Rise 17.9 Percent; Net Earnings Increase 26.3 Percent
Jul. 23, 2008
Teva Completes Acquisition of Bentley Pharmaceuticals
Jul. 23, 2008
Elan and Wyeth Announce Webcast To Discuss Bapineuzumab Phase 2 Clinical Trial Results
Jul. 16, 2008
Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
Jul. 16, 2008
Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering
Jul. 15, 2008
Leslie A. "Les" Brun Elected to Merck Board of Directors
Jul. 15, 2008
Medtronic Launches First Insertable Cardiac Monitor in Japan
Jul. 9, 2008
Investigational New Drug Application Submitted On Behalf of Generex Biotechnology for Combination Immunotherapy Vaccine Trials
Jul. 9, 2008
Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
Jul. 9, 2008
Abbott Begins Post-Approval Study of XIENCE V
TM
Drug Eluting Stent
Jul. 2, 2008
Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
Jul. 2, 2008
Alkermes Presents Positive Data on Proprietary Molecules Targeting Opioid Receptors
Jul. 2, 2008
Boston Scientific Announces FDA Approval for PROMUS Everolimus-Eluting Coronary Stent System
Copyright ©2003-2010 LifeScienceTimes.com
All Rights Reserved.